Out-licensing: Fenofibrate 160 Mg Tablet

Latest: Watch here for details of new products and services.

About Us: Pharmalicensing - Partnering solutions for the life sciences
Our Products: Overview; Partnering Search; Company Profiling; Deal Negotiation; PL Intelligence; Reports; Comparison
PL Intelligence: Overview; Industry news; Deals review; Press releases; Articles
Case Studies: See what others think about our service
Newsletter: Partnering update; Key reports; Subscribe
Quick Links: Profile now; Register now; Profiled companies; Featured events; Industry news; PR Newswire; Jobs
Contact Pharmalicensing: Send an email; Call us: +44 1904 520460; Request a callback
RSS Feeds: Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd

Generic dossier

Generic dossier - European registration procedure about to start

Registered

Out-licensing opportunities for many EU countries.

Are you looking for reports related to this particular subject. Our Reports section is the best place to start.

Therapeutic target: Cardiovascular / Blood composition / Dyslipidemia; Cardiovascular / Blood composition / Hypercholesterolemia; Cardiovascular / Blood composition / Hyperlipidemia; Cardiovascular / Blood composition / Hypertriglyceridemia

Clients in focus...

Get the Flash Player to see this rotator.

Press releases: Pharmalicensing current industry press releases.